Onco KEM®, a novel decision support system helping oncologists to personalize cancer
treatments according to the molecular profile of each patient.
Onco KEM® helps oncologists choose optimal therapeutics for each patient, providing a
personalized ranking of existing treatments.
Onco KEM® goes beyond DNA analysis including the differential analysis of RNA expression in
tumors.
Onco KEM® has been successfully tested for over 100 patients, through the world’s first
international multi-centric personalized medicine clinical trial,
WINTHER.